医学
甲状腺球蛋白
内科学
甲状腺癌
甲状腺过氧化物酶
恶性肿瘤
胃肠病学
甲状腺
优势比
卵泡期
内分泌学
抗甲状腺自身抗体
自身抗体
抗体
免疫学
作者
Zhijiang Chen,Yinghe Lin,Shuiqing Lai,Peiqing Wang,Jinlian Li,Long Wang,Haixia Guan,Jian Kuang
出处
期刊:Endocrine
[Springer Science+Business Media]
日期:2022-02-02
卷期号:76 (2): 369-376
被引量:20
标识
DOI:10.1007/s12020-022-02993-1
摘要
Abstract PurposeIt is challenging to distinguish follicular thyroid carcinoma (FTC) from follicular thyroid adenoma (FTA) before surgery due to the lack of malignant ultrasound features, the underdiagnosis by fine-needle biopsy, and the absence of definitive markers. We investigated whether thyroglobulin (Tg), anti-thyroglobulin antibody (TgAb), thyroid peroxidase antibodies (TPOAb), and thyroid stimulating hormone (TSH) could help differentiate FTC from FTA.MethodsA total of 319 patients with follicular neoplasms were included. We analyzed the serum markers as continuous and categorical variables between FTC and FTA. Also, we analyzed the prevalence of FTC in different serum markers groups.ResultsThe TgAb was a risk factor of FTC. Versus the TgAb group (≤11.68 IU/mL), OR of the group (11.69-30.50 IU/mL) and the group (>30.50 IU/mL) were 2.206 (1.114-4.369, P=0.023) and 3.247 (1.684-6.260, P<0.001), respectively. Versus the TgAb group (≤11.68 IU/mL), the malignant prevalence of the group (>30.50 IU/mL) was higher (13.1% vs. 32.9%, P=0.001). In TgAb (-) patients, the Tg was another risk factor of FTC. Versus the Tg group (≤38.51 ng/mL), OR of the group (>434.60 ng/mL) was 3.836 (1.625-9.058, P=0.002); the malignant prevalence of the group (>434.60 ng/mL) was 47.2% and higher than other groups.ConclusionsThe TgAb and Tg may have utility in the preoperative differential diagnosis of follicular neoplasm. The higher TgAb and Tg were associated with higher malignant risk. Thus, we should be cautious of preoperative TgAb and Tg in follicular neoplasm.
科研通智能强力驱动
Strongly Powered by AbleSci AI